These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33791153)

  • 1. Establishment of patient-derived xenograft models of adenoid cystic carcinoma to assess pre-clinical efficacy of combination therapy of a PI3K inhibitor and retinoic acid.
    Sun B; Wang Y; Sun J; Zhang C; Xia R; Xu S; Sun S; Li J
    Am J Cancer Res; 2021; 11(3):773-792. PubMed ID: 33791153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
    Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.
    Thierauf J; Ramamurthy N; Jo VY; Robinson H; Frazier RP; Gonzalez J; Pacula M; Dominguez Meneses E; Nose V; Nardi V; Dias-Santagata D; Le LP; Lin DT; Faquin WC; Wirth LJ; Hess J; Iafrate AJ; Lennerz JK
    Oncologist; 2019 Oct; 24(10):1356-1367. PubMed ID: 30926674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.
    Humtsoe JO; Kim HS; Jones L; Cevallos J; Boileau P; Kuo F; Morris LGT; Ha P
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.
    Jiang Y; Gao R; Cao C; Forbes L; Li J; Freeberg S; Fredenburg KM; Justice JM; Silver NL; Wu L; Varma S; West R; Licht JD; Zajac-Kaye M; Kentsis A; Kaye FJ
    Oral Oncol; 2019 Nov; 98():147-155. PubMed ID: 31606723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
    Brayer KJ; Frerich CA; Kang H; Ness SA
    Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity and therapeutic target detection through microdissection in solid-type adenoid cystic carcinoma.
    Wang Y; Sun B; Zhang C; Xia R; Sun J; Gu T; Tian Z; Li J
    Pathology; 2022 Aug; 54(5):580-590. PubMed ID: 35337667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.
    Kyrpychova L; Vanecek T; Grossmann P; Martinek P; Steiner P; Hadravsky L; Belousova IE; Shelekhova KV; Svajdler M; Dubinsky P; Michal M; Kazakov DV
    Am J Dermatopathol; 2018 Oct; 40(10):721-726. PubMed ID: 29570128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma.
    Andersson MK; Mangiapane G; Nevado PT; Tsakaneli A; Carlsson T; Corda G; Nieddu V; Abrahamian C; Chayka O; Rai L; Wick M; Kedaigle A; Stenman G; Sala A
    Oncogenesis; 2020 Jan; 9(1):5. PubMed ID: 32001675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
    Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
    Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study.
    Persson M; Andersson MK; Mitani Y; Brandwein-Weber MS; Frierson HF; Moskaluk C; Fonseca I; Ferrarotto R; Boecker W; Loening T; El-Naggar AK; Stenman G
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
    Kang HN; Kim JH; Park AY; Choi JW; Lim SM; Kim J; Shin EJ; Hong MH; Pyo KH; Yun MR; Kim DH; Lee H; Yoon SO; Kim DH; Park YM; Byeon HK; Jung I; Paik S; Koh YW; Cho BC; Kim HR
    BMC Cancer; 2020 Apr; 20(1):316. PubMed ID: 32293356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
    Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
    Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
    Bishop JA; Yonescu R; Epstein JI; Westra WH
    Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14).
    Warner KA; Herzog AE; Sahara S; Nör F; Castilho RM; Demirci H; Chepeha DB; Polverini PJ; Nör JE
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Oct; 138(4):516-531. PubMed ID: 38971694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.
    Bieniasz M; Radhakrishnan P; Faham N; De La O JP; Welm AL
    Clin Cancer Res; 2015 Dec; 21(24):5588-600. PubMed ID: 26289070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
    Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
    J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.